Close
San Antonio Liver Cancer Symposium
Friday, October 11, 2024
to
Saturday, October 12, 2024
Registration opens June 1
-
About
About This Event
Mays Cancer Center at UT Health San Antonio invites you to our annual San Antonio Liver Cancer Symposium (SALCS) at the Hilton Palacio del Rio in downtown San Antonio on Oct. 11-12, 2024.
Join us for a two-day symposium filled with engaging sessions and interactive panel discussions to promote collaboration and advance liver cancer knowledge. This meeting will cover the epidemiology of liver cancer and explore the latest pre-clinical, translational and clinical breakthroughs in its treatment, encompassing survivorship care and pediatric liver cancer. We welcome the liver cancer community, along with physicians, researchers, nurses and providers, to participate and contribute to this enriching experience.
Topics include:
- Exploring pediatric management of hepatoblastoma, including its molecular signatures and novel therapies.
- Examining the controversies in transplantation.
- Growing community liver cancer programs to enhance patient care and support.
- Developing personalized programs for non-viral versus viral hepatitis/cirrhosis.
- Gaining insights into the current therapeutic landscape for hepatocellular carcinoma.
- Discussing the shifting paradigms in locoregional treatments: surgical advancements, interventional radiology and transplant innovations.
Why you should attend:
- Increase your knowledge of liver cancer treatment.
- Receive a comprehensive update on the latest scientific, clinical and translational advancements in liver cancer.
- Listen and participate in dynamic discussions led by clinicians and researchers.
- Connect with renowned experts in liver cancer who will be presenting at the conference.
- Earn CME, MOC and CNE credits.
CALL FOR ABSTRACTS! Undergraduate, graduate/predoctoral, and postdoctoral students and fellows are invited to submit an abstract for the San Antonio Liver Cancer Symposium by July 1. See below for abstract instructions.
-
Agenda
Agenda
Agenda coming soon.
-
Date and Time
Date and Time
- Friday, October 11, 2024, 7:00AM
- to Saturday, October 12, 2024, 3:30PM
-
Location
Location
-
Call for Abstracts
Call for Abstracts
Submit an abstract!
DEADLINE: July 1, 2024
Abstract categories:
- Cancer disparities
- Diagnostics (including biomarkers and precision medicine)
- Patient-reported outcomes and real-world evidence
- Pediatrics
- Prevention and screening
- Surgical management
- Survivorship
- Therapeutics (i.e., interventional, radiation and systemic)
- Translational research
- Tumor biology, biomarkers and pathology
- Other
Abstract instructions:
- Abstracts must include all authors and their institutions.
- Disclosure information for all authors must be included.
- Identify the lead author with an asterisk.
- Awards will be offered, and the top three posters will be presented during the symposium on Friday, October 11, 2024.
- Up to three references are allowed. These should be cited numerically in the text and placed under “References Cited” with titles included.
- Abbreviations can be used as long they are defined at their first mention in the text.
- The author and institution list is not included in the character limit.
- The lead/primary author listed on the abstract must be registered and present at the conference.
- Accepted abstracts - presenters will be notified by e-mail in September 2024.
- Presenters are responsible for producing and printing their posters if they are accepted for a poster. The Instructions for the poster printing will be sent to accepted abstracts.
- All accepted posters will be able to be presented during the evening poster session on Friday, October 11, 2024.
Submit an abstract!
DEADLINE: July 1, 2024
-
Contact
Contact
For questions about the symposium, please send an email to UTHealthMTG@uthscsa.edu.
-
Exhibitor Details
Exhibitor Details
For exhibitor inquiries, please send an email to UTHealthMTG@uthscsa.edu.